EX-23.1
Published on March 5, 2026
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333- 291386) of Evommune, Inc. (the Company) of our report dated March 5, 2026, relating to the consolidated financial statements which appears in this annual Report on Form 10-K.
/s/ BDO USA, P.C.
New York, New York
March 5, 2026